Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

Minoxidil improves quality of life for women with hair loss.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

No link found between new male baldness genes and female hair loss.

Low-level light therapy may help hair regrowth, but more research is needed.

Both genetic and lifestyle factors significantly affect female hair loss.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Spironolactone and minoxidil together effectively treat female pattern hair loss.

Women with PCOS may be more likely to have gum disease than healthy women.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Women with PCOS often have more sleep problems than the general population.

PRP injections improve hair density and thickness in women with hair loss.

No link found between specific genes and female pattern hair loss.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.